TODD S. YOUNG - 01 Mar 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President and Chief Financial Officer
Signature
/s/ Catherine S. Powell, as Attorney-in-Fact for Todd S. Young
Issuer symbol
ELAN
Transactions as of
01 Mar 2023
Net transactions value
-$87,278
Form type
4
Filing time
03 Mar 2023, 20:09:38 UTC
Previous filing
03 Feb 2023
Next filing
06 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Tax liability $63,056 -5,600 -4.7% $11.26 114,349 01 Mar 2023 Direct F1
transaction ELAN Common Stock Award $0 +58,060 +51% $0.000000 172,409 01 Mar 2023 Direct F2
transaction ELAN Common Stock Tax liability $24,222 -2,200 -1.3% $11.01 168,620 02 Mar 2023 Direct F1, F3
holding ELAN Common Stock 6,562 01 Mar 2023 By IRA
holding ELAN Common Stock 2,000 01 Mar 2023 By J. G. Young IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option (right to buy) Award $0 +132,607 $0.000000 132,607 01 Mar 2023 Common Stock 132,607 $11.26 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
F2 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.
F3 Balance reflects 1,589 fewer shares due to an error in the number of shares previously reported as forfeited in a prior Form 4.
F4 Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

Remarks:

Executive Vice President and Chief Financial Officer